查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2106324

女性荷爾蒙健康補充劑市場預測（至2034年）：按產品類型、成分、劑型、分銷管道、應用、最終用戶和地區分類的全球分析

Women's Hormonal Wellness Supplements Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient, Form, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，到 2026 年，全球女性荷爾蒙保健補充劑市場規模預計將達到 100 億美元，並在預測期內以 8.9% 的複合年成長率成長，到 2034 年將達到 167 億美元。

女性荷爾蒙平衡補充劑是一種專門配製的營養配方，旨在支持女性從青春期到更年期及以後整個生命週期的內分泌平衡、生殖健康和荷爾蒙變化。這些產品含有植物萃取物、維生素、礦物質和生物活性物質，能夠影響雌激素代謝、黃體素合成、皮質醇調節和甲狀腺功能。其技術包括植物雌激素的標準化、適應原草藥的萃取以及配方科學，以確保長期使用的生物利用度和安全性。

更年期意識宣傳活動

隨著全球範圍內對更年期的偏見逐漸消退，以及關於激素健康的社會討論日益增多，女性激素保健補充劑的需求激增，因為它們無需處方箋即可輕鬆獲取。由名人及醫療機構發起的高調宣傳宣傳活動，使得圍閉經和更年期症狀的討論變得司空見慣。人們對合成荷爾蒙相關的心血管疾病和癌症風險的擔憂，促使越來越多的女性尋求荷爾蒙補充療法的天然替代方案。 45-65歲年齡層的人是一個龐大且經濟實力雄厚的消費群體，擁有強大的購買力。商業性，這預示著市場將從小眾的天然保健管道擴展到主流零售和醫療保健推薦領域。

缺乏臨床證據

支持植物來源荷爾蒙平衡成分有效性的大規模隨機對照試驗數量有限，這在醫療保健專業人員和懷疑的消費者中造成了信任障礙。許多常用成分，例如黑升麻、聖潔莓和瑪卡根，依賴傳統用法和小規模試驗研究，而非嚴謹的臨床檢驗。包括美國食品藥物管理局 (FDA) 和歐洲食品安全局 (EFSA) 在內的監管機構對健康聲明有著嚴格的標準，而大多數植物性膳食補充劑都未能達到這些標準。證據的缺乏限制了醫療保健專業人員的推薦，並將市場宣傳限制在模糊的「健康」術語而非具體的治療效果上，從而限制了其高價銷售的可能性。

按生命週期進行細分

針對不同年齡和生命階段開發荷爾蒙健康配方，為產品系列停經後消費者生命各個階段閉經的產品，並隨著他們的需求不斷調整。最終用戶將受益於精準配方的產品，而非普通的女性用綜合維他命。市場趨勢青睞那些能夠全面覆蓋整個生命週期的品牌，這些品牌能夠創造多個觸點，並在長達數十年的消費週期中提升客戶的終身價值。

荷爾蒙療法的進展

生物同源荷爾蒙補充療法和治療更年期症狀及荷爾蒙失調的新型藥物療法的不斷進步，給植物來源補充劑帶來了競爭壓力。生物同源製劑提供的荷爾蒙分子結構與天然荷爾蒙完全相同，與傳統的合成荷爾蒙相比，安全性更高。用於緩解潮熱和情緒波動的新型非荷爾蒙處方藥也提供了經臨床驗證的替代方案。醫療保健專業人員對現代荷爾蒙療法越來越熟悉，他們可能會推薦這些藥物而非補充劑。這些藥物領域的進步可能會促使消費者減少對植物來源荷爾蒙保健產品的支出，尤其是那些症狀嚴重、尋求快速緩解的女性。

新型冠狀病毒（COVID-19）的影響：

新冠疫情擾亂了女性荷爾蒙保健品的供應鏈和臨床研究計劃，同時也凸顯了女性體內荷爾蒙活躍狀態下免疫力和整體健康的重要性。疫情封鎖期間的壓力導致荷爾蒙失衡，使得人們對適應原和平衡補充劑的需求增加。遠距遠端醫療的普及提高了女性獲得荷爾蒙健康諮詢服務的便利性，而這些諮詢通常會建議補充營養。疫情過後，人們對整體健康和預防性醫療保健的持續關注預計將進一步推動對女性荷爾蒙健康的投資，將其作為綜合健康管理的基礎。

在預測期內，綜合維他命補充劑細分市場預計將佔據最大的市場佔有率。

由於消費者對其廣泛的認可度、強大的零售市場佔有率以及綜合維他命作為荷爾蒙健康基礎產品所提供的全面營養，預計綜合維他命補充劑將在預測期內佔據最大的市場佔有率。女性綜合維他命含有針對女性各個生命階段生理需求的鐵、葉酸、B群維生素和維生素D。醫療保健專業人員經常建議在採取特定疾病干預措施之前，將綜合維他命作為基礎營養支持。終端用戶也十分欣賞其將所有營養成分整合於一身的便利性。該細分市場的主導地位反映了其在普通消費者中的可及性、價格優勢和信譽。

預計在預測期內，睡茄細分市場將呈現最高的複合年成長率。

在預測期內，睡茄）細分市場預計將呈現最高的成長率，這主要得益於越來越多的臨床證據表明其具有適應原作用，能夠調節皮質醇、甲狀腺功能以及與壓力相關的激素失衡，尤其是在女性健康方面。同行評審的研究表明，睡茄根萃取物能夠顯著降低壓力生物標記水平，並改善生殖激素水平。其產品形式多樣，包括膠囊、粉末和機能飲料，正在加速產品配方的創新。消費者對阿育吠陀養生傳統的熟悉程度增強了他們的信任度和嘗試意願。關鍵市場的監管批准正在推動其廣泛分銷。壓力管理和荷爾蒙平衡調節應用的融合正在推動跨品類成長。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其龐大的圍閉經和閉經女性人口、成熟的保健品消費文化、強大的直銷品牌生態系統以及醫療保健專業人員對整合醫學方法的積極參與。美國憑藉著成熟的女性健康保健品品牌、強大的電子商務基礎設施以及在社群媒體上頗具影響力的健康社群，在市場中處於領先地位。加拿大也展現出類似的消費者偏好，並擁有完善的天然保健品法規結構。在墨西哥，中產階級的壯大和健康意識的提升正在催生新的需求。該地區先進的行銷能力能夠有效地針對人生階段的轉變進行精準行銷。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、印度、日本和東南亞龐大的女性人口、不斷成長的可支配收入、日益增強的健康意識以及根深蒂固的傳統醫學文化（強調植物來源性激素平衡）。在中國，傳統中醫與現代保健品的融合正在創造一系列獨特的產品。在印度，阿育吠陀傳統支撐著對睡茄和蘆筍的需求。在日本，女性人口老化推動了更年期健康領域的創新。在韓國，美容養生文化正延伸至內在健康。電子商務的蓬勃發展使消費者能夠直接接觸國際品牌。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性評估）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球女性荷爾蒙健康補充品市場：依產品類型分類

  • 綜合維他命補充劑
  • 草藥補充劑
  • 益生菌補充劑
  • Omega脂肪酸補充劑
  • 蛋白質補充劑
  • 複合補充劑
  • 其他產品類型

第6章：全球女性荷爾蒙健康補充品市場：依成分分類

  • 黑升麻
  • 睡茄
  • 瑪卡根
  • 月見草油
  • 大豆異黃酮
  • 聖潔莓
  • 維生素和礦物質
  • 其他成分

第7章：全球女性荷爾蒙健康補充品市場：以劑型分類

  • 膠囊
  • 藥片
  • 粉末
  • 軟糖
  • 液體類型
  • 軟凝膠

第8章：全球女性荷爾蒙健康補充品市場：按分銷管道分類

  • 藥局
  • 超級市場和大賣場
  • 健康食品店
  • 線上零售
  • 直銷
  • 專賣店

第9章：全球女性荷爾蒙健康補充品市場：按應用領域分類

  • 月經健康
  • 生育支持
  • 更年期支持
  • 卵巢症候群（PCOS）的管理
  • 懷孕健康
  • 一般荷爾蒙平衡調整

第10章：全球女性荷爾蒙健康補充品市場：以最終用戶分類

  • 青春期
  • 育齡婦女
  • 孕婦
  • 閉經婦女
  • 停經後婦女

第11章：全球女性荷爾蒙健康補充品市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Bayer AG
  • Haleon plc
  • Herbalife Ltd.
  • Amway Corporation
  • The Nature's Bounty Co.
  • Blackmores Limited
  • Swisse Wellness Pty Ltd.
  • Garden of Life
  • Now Health Group, Inc.
  • New Chapter, Inc.
  • Thorne HealthTech, Inc.
  • Jamieson Wellness Inc.
  • Metagenics, Inc.
  • Integria Healthcare
  • SmartyPants Vitamins
  • Life Extension
  • NutraMarks, Inc.
Product Code: SMRC38504

According to Stratistics MRC, the Global Women's Hormonal Wellness Supplements Market is accounted for $10.0 billion in 2026 and is expected to reach $16.7 billion by 2034 growing at a CAGR of 8.9% during the forecast period. Women's hormonal wellness supplements are specialized nutritional formulations designed to support endocrine balance, reproductive health, and hormonal transitions across the female lifecycle from adolescence through menopause and beyond. These products contain botanical extracts, vitamins, minerals, and bioactive compounds that influence estrogen metabolism, progesterone synthesis, cortisol regulation, and thyroid function. The technology encompasses phytoestrogen standardization, adaptogenic herb extraction, and formulation science that ensures bioavailability and safety for long-term consumption.

Market Dynamics:

Driver:

Menopause awareness campaigns

The global destigmatization of menopause and increased public discourse around hormonal health is driving substantial demand for women's hormonal wellness supplements as accessible, non-prescription solutions. High-profile awareness campaigns by celebrities and healthcare organizations have normalized conversations about perimenopausal and menopausal symptoms. Women increasingly seek natural alternatives to hormone replacement therapy due to concerns about cardiovascular and cancer risks associated with synthetic hormones. End users in the forty-five to sixty-five age demographic represent a large, affluent consumer base with significant purchasing power. The commercial implication is a mainstream market expansion beyond niche natural health channels into conventional retail and healthcare recommendations.

Restraint:

Clinical evidence gaps

The limited volume of large-scale, randomized controlled trials supporting the efficacy of botanical hormonal wellness ingredients creates credibility barriers with healthcare providers and skeptical consumers. Many popular ingredients, including black cohosh, chasteberry, and maca root rely on traditional use evidence and small pilot studies rather than robust clinical validation. Regulatory agencies, including the FDA and EFSA, maintain strict standards for health claims that most botanical supplements cannot satisfy. These evidence gaps limit healthcare practitioner endorsement and restrict marketing claims to vague wellness language rather than specific therapeutic outcomes, constraining premium pricing potential.

Opportunity:

Lifecycle segmentation

The development of age and life-stage-specific hormonal wellness formulations presents transformative opportunities for targeted product portfolios that address the distinct physiological needs of adolescents, reproductive-age women, pregnant women, perimenopausal women, and postmenopausal women. Each life stage presents unique hormonal challenges requiring different botanical and nutrient combinations. Personalized subscription models deliver stage-appropriate products that evolve with the consumer. End users benefit from precise formulations rather than generic women's multivitamins. The commercial momentum favors brands that offer comprehensive lifecycle coverage, creating multiple touchpoints and extended customer lifetime value across decades of consumption.

Threat:

Hormone therapy advances

Continuous improvements in bioidentical hormone replacement therapy and novel pharmaceutical treatments for menopausal symptoms and hormonal disorders pose competitive threats to botanical supplement alternatives. Bioidentical formulations offer molecularly identical hormones with improved safety profiles compared to synthetic predecessors. New non-hormonal prescription medications for hot flashes and mood disturbances provide clinically validated alternatives. Healthcare providers increasingly comfortable with modern hormone therapy may recommend these over supplements. These pharmaceutical advances could redirect consumer spending away from botanical hormonal wellness products, particularly among women with severe symptoms seeking rapid relief.

Covid-19 Impact:

The COVID-19 pandemic disrupted women's hormonal wellness supplement supply chains and clinical research timelines while simultaneously highlighting the importance of immune and overall health for hormonally active women. Stress-induced hormonal imbalances during lockdowns increased interest in adaptogenic and balancing supplements. Telemedicine expansion improved access to hormone health consultations that often recommend nutritional support. Post-pandemic, sustained focus on holistic wellness and preventive healthcare supports continued investment in women's hormonal wellness as a foundation of integrated health management.

The multivitamin supplements segment is expected to be the largest during the forecast period

The multivitamin supplements segment is expected to account for the largest market share during the forecast period, due to the broad consumer familiarity, established retail presence, and comprehensive nutrient coverage that multivitamins provide as foundational hormonal wellness products. Women's specific multivitamins incorporate iron, folate, B vitamins, and vitamin D at concentrations tailored to female physiological needs across life stages. Healthcare practitioners frequently recommend multivitamins as baseline nutritional support before condition-specific interventions. End users appreciate the convenience of single-product solutions. The commercial dominance reflects the segment's accessibility, affordability, and trusted status among mainstream consumers.

The ashwagandha segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ashwagandha segment is predicted to witness the highest growth rate, driven by expanding clinical evidence of its adaptogenic effects on cortisol regulation, thyroid function, and stress-related hormonal imbalances specifically relevant to women's health. Ashwagandha root extracts demonstrate measurable reductions in stress biomarkers and improvements in reproductive hormone profiles in peer-reviewed studies. The ingredient's versatility across capsules, powders, and functional beverages accelerates format innovation. Consumer familiarity with Ayurvedic wellness traditions supports trust and trial. Regulatory acceptance in major markets enables broad distribution. The convergence of stress management and hormonal balance applications creates cross-category growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the large population of perimenopausal and menopausal women, high supplement consumption culture, an extensive direct-to-consumer brand ecosystem, and strong healthcare practitioner engagement with integrative medicine approaches. The United States leads with established women's health supplement brands, robust e-commerce infrastructure, and influential social media wellness communities. Canada demonstrates similar consumer preferences with progressive regulatory frameworks for natural health products. Mexico's growing middle class and increasing health awareness create emerging demand. The region's advanced marketing capabilities effectively target life-stage transitions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to large female populations, rising disposable incomes, growing health consciousness, and the deep cultural roots of traditional medicine systems that emphasize botanical hormonal balance across China, India, Japan, and Southeast Asia. China's integration of Traditional Chinese Medicine with modern supplement formats creates unique product offerings. India's Ayurvedic heritage supports the demand for ashwagandha and shatavari. Japan's aging female population drives menopausal wellness innovation. South Korea's beauty and wellness culture extends to inner health. E-commerce penetration enables direct access to international brands.

Key players in the market

Some of the key players in Women's Hormonal Wellness Supplements include Bayer AG, Haleon plc, Herbalife Ltd., Amway Corporation, The Nature's Bounty Co., Blackmores Limited, Swisse Wellness Pty Ltd., Garden of Life, Now Health Group, Inc., New Chapter, Inc., Thorne HealthTech, Inc., Jamieson Wellness Inc., Metagenics, Inc., Integria Healthcare, SmartyPants Vitamins, Life Extension and NutraMarks, Inc.

Key Developments:

In June 2026, Bayer AG launched a comprehensive women's hormonal wellness supplement line targeting perimenopausal symptoms, combining black cohosh, ashwagandha, and vitamin D in a clinically validated formulation for hot flash and mood support.

In May 2026, Haleon plc expanded its women's health portfolio with a menopause-focused supplement range featuring phytoestrogen-rich ingredients and adaptogenic herbs, supported by a digital symptom tracking app for personalized wellness management.

In April 2026, Garden of Life introduced a certified organic prenatal and pregnancy wellness supplement system with hormonal balance support, utilizing whole-food sourced vitamins and botanicals for expectant mothers across trimesters.

Product Types Covered:

  • Multivitamin Supplements
  • Herbal Supplements
  • Probiotic Supplements
  • Omega Fatty Acid Supplements
  • Protein Supplements
  • Combination Supplements
  • Other Product Types

Ingredients Covered:

  • Black Cohosh
  • Ashwagandha
  • Maca Root
  • Evening Primrose Oil
  • Soy Isoflavones
  • Chasteberry
  • Vitamins and Minerals
  • Other Ingredients

Forms Covered:

  • Capsules
  • Tablets
  • Powders
  • Gummies
  • Liquids
  • Softgels

Distribution Channels Covered:

  • Pharmacies
  • Supermarkets and Hypermarkets
  • Health Stores
  • Online Retail
  • Direct Sales
  • Specialty Stores

Applications Covered:

  • Menstrual Health
  • Fertility Support
  • Menopause Support
  • PCOS Management
  • Pregnancy Wellness
  • General Hormonal Balance

End Users Covered:

  • Adolescents
  • Reproductive Age Women
  • Pregnant Women
  • Perimenopausal Women
  • Postmenopausal Women

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Women's Hormonal Wellness Supplements Market, By Product Type

  • 5.1 Multivitamin Supplements
  • 5.2 Herbal Supplements
  • 5.3 Probiotic Supplements
  • 5.4 Omega Fatty Acid Supplements
  • 5.5 Protein Supplements
  • 5.6 Combination Supplements
  • 5.7 Other Product Types

6 Global Women's Hormonal Wellness Supplements Market, By Ingredient

  • 6.1 Black Cohosh
  • 6.2 Ashwagandha
  • 6.3 Maca Root
  • 6.4 Evening Primrose Oil
  • 6.5 Soy Isoflavones
  • 6.6 Chasteberry
  • 6.7 Vitamins and Minerals
  • 6.8 Other Ingredients

7 Global Women's Hormonal Wellness Supplements Market, By Form

  • 7.1 Capsules
  • 7.2 Tablets
  • 7.3 Powders
  • 7.4 Gummies
  • 7.5 Liquids
  • 7.6 Softgels

8 Global Women's Hormonal Wellness Supplements Market, By Distribution Channel

  • 8.1 Pharmacies
  • 8.2 Supermarkets and Hypermarkets
  • 8.3 Health Stores
  • 8.4 Online Retail
  • 8.5 Direct Sales
  • 8.6 Specialty Stores

9 Global Women's Hormonal Wellness Supplements Market, By Application

  • 9.1 Menstrual Health
  • 9.2 Fertility Support
  • 9.3 Menopause Support
  • 9.4 PCOS Management
  • 9.5 Pregnancy Wellness
  • 9.6 General Hormonal Balance

10 Global Women's Hormonal Wellness Supplements Market, By End User

  • 10.1 Adolescents
  • 10.2 Reproductive Age Women
  • 10.3 Pregnant Women
  • 10.4 Perimenopausal Women
  • 10.5 Postmenopausal Women

11 Global Women's Hormonal Wellness Supplements Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Bayer AG
  • 14.2 Haleon plc
  • 14.3 Herbalife Ltd.
  • 14.4 Amway Corporation
  • 14.5 The Nature's Bounty Co.
  • 14.6 Blackmores Limited
  • 14.7 Swisse Wellness Pty Ltd.
  • 14.8 Garden of Life
  • 14.9 Now Health Group, Inc.
  • 14.10 New Chapter, Inc.
  • 14.11 Thorne HealthTech, Inc.
  • 14.12 Jamieson Wellness Inc.
  • 14.13 Metagenics, Inc.
  • 14.14 Integria Healthcare
  • 14.15 SmartyPants Vitamins
  • 14.16 Life Extension
  • 14.17 NutraMarks, Inc.

List of Tables

  • Table 1 Global Women's Hormonal Wellness Supplements Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Women's Hormonal Wellness Supplements Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Women's Hormonal Wellness Supplements Market Outlook, By Multivitamin Supplements (2023-2034) ($MN)
  • Table 4 Global Women's Hormonal Wellness Supplements Market Outlook, By Herbal Supplements (2023-2034) ($MN)
  • Table 5 Global Women's Hormonal Wellness Supplements Market Outlook, By Probiotic Supplements (2023-2034) ($MN)
  • Table 6 Global Women's Hormonal Wellness Supplements Market Outlook, By Omega Fatty Acid Supplements (2023-2034) ($MN)
  • Table 7 Global Women's Hormonal Wellness Supplements Market Outlook, By Protein Supplements (2023-2034) ($MN)
  • Table 8 Global Women's Hormonal Wellness Supplements Market Outlook, By Combination Supplements (2023-2034) ($MN)
  • Table 9 Global Women's Hormonal Wellness Supplements Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 10 Global Women's Hormonal Wellness Supplements Market Outlook, By Ingredient (2023-2034) ($MN)
  • Table 11 Global Women's Hormonal Wellness Supplements Market Outlook, By Black Cohosh (2023-2034) ($MN)
  • Table 12 Global Women's Hormonal Wellness Supplements Market Outlook, By Ashwagandha (2023-2034) ($MN)
  • Table 13 Global Women's Hormonal Wellness Supplements Market Outlook, By Maca Root (2023-2034) ($MN)
  • Table 14 Global Women's Hormonal Wellness Supplements Market Outlook, By Evening Primrose Oil (2023-2034) ($MN)
  • Table 15 Global Women's Hormonal Wellness Supplements Market Outlook, By Soy Isoflavones (2023-2034) ($MN)
  • Table 16 Global Women's Hormonal Wellness Supplements Market Outlook, By Chasteberry (2023-2034) ($MN)
  • Table 17 Global Women's Hormonal Wellness Supplements Market Outlook, By Vitamins and Minerals (2023-2034) ($MN)
  • Table 18 Global Women's Hormonal Wellness Supplements Market Outlook, By Other Ingredients (2023-2034) ($MN)
  • Table 19 Global Women's Hormonal Wellness Supplements Market Outlook, By Form (2023-2034) ($MN)
  • Table 20 Global Women's Hormonal Wellness Supplements Market Outlook, By Capsules (2023-2034) ($MN)
  • Table 21 Global Women's Hormonal Wellness Supplements Market Outlook, By Tablets (2023-2034) ($MN)
  • Table 22 Global Women's Hormonal Wellness Supplements Market Outlook, By Powders (2023-2034) ($MN)
  • Table 23 Global Women's Hormonal Wellness Supplements Market Outlook, By Gummies (2023-2034) ($MN)
  • Table 24 Global Women's Hormonal Wellness Supplements Market Outlook, By Liquids (2023-2034) ($MN)
  • Table 25 Global Women's Hormonal Wellness Supplements Market Outlook, By Softgels (2023-2034) ($MN)
  • Table 26 Global Women's Hormonal Wellness Supplements Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 27 Global Women's Hormonal Wellness Supplements Market Outlook, By Pharmacies (2023-2034) ($MN)
  • Table 28 Global Women's Hormonal Wellness Supplements Market Outlook, By Supermarkets and Hypermarkets (2023-2034) ($MN)
  • Table 29 Global Women's Hormonal Wellness Supplements Market Outlook, By Health Stores (2023-2034) ($MN)
  • Table 30 Global Women's Hormonal Wellness Supplements Market Outlook, By Online Retail (2023-2034) ($MN)
  • Table 31 Global Women's Hormonal Wellness Supplements Market Outlook, By Direct Sales (2023-2034) ($MN)
  • Table 32 Global Women's Hormonal Wellness Supplements Market Outlook, By Specialty Stores (2023-2034) ($MN)
  • Table 33 Global Women's Hormonal Wellness Supplements Market Outlook, By Application (2023-2034) ($MN)
  • Table 34 Global Women's Hormonal Wellness Supplements Market Outlook, By Menstrual Health (2023-2034) ($MN)
  • Table 35 Global Women's Hormonal Wellness Supplements Market Outlook, By Fertility Support (2023-2034) ($MN)
  • Table 36 Global Women's Hormonal Wellness Supplements Market Outlook, By Menopause Support (2023-2034) ($MN)
  • Table 37 Global Women's Hormonal Wellness Supplements Market Outlook, By PCOS Management (2023-2034) ($MN)
  • Table 38 Global Women's Hormonal Wellness Supplements Market Outlook, By Pregnancy Wellness (2023-2034) ($MN)
  • Table 39 Global Women's Hormonal Wellness Supplements Market Outlook, By General Hormonal Balance (2023-2034) ($MN)
  • Table 40 Global Women's Hormonal Wellness Supplements Market Outlook, By End User (2023-2034) ($MN)
  • Table 41 Global Women's Hormonal Wellness Supplements Market Outlook, By Adolescents (2023-2034) ($MN)
  • Table 42 Global Women's Hormonal Wellness Supplements Market Outlook, By Reproductive Age Women (2023-2034) ($MN)
  • Table 43 Global Women's Hormonal Wellness Supplements Market Outlook, By Pregnant Women (2023-2034) ($MN)
  • Table 44 Global Women's Hormonal Wellness Supplements Market Outlook, By Perimenopausal Women (2023-2034) ($MN)
  • Table 45 Global Women's Hormonal Wellness Supplements Market Outlook, By Postmenopausal Women (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.